New drug shrinks prostate tumors
An experimental cancer drug shrank prostate tumors dramatically and more than doubled survival in 70 percent to 80 percent of patients with aggressive cancers, British researchers reported Tuesday.

An experimental cancer drug shrank prostate tumors dramatically and more than doubled survival in 70 percent to 80 percent of patients with aggressive cancers, British researchers reported Tuesday.
They are also the first in the world to use this technology to deliver stereotactic body radiotherapy in the treatment of soft tissue carcinoma.
Unnecessary biopsies could be a thing of the past for patients undergoing treatment for head and neck cancer.
Submitted by News Account on 22 July 2008 - 4:15am. Public Health We are continuously bombarded with messages about the dangers of too much sun and the increased risk of melanoma , but are these dangers real, ...
A South Carolina breast-cancer survivor has beaten the State Department and convinced judges in Washington that the inability to have sex is a disability protected under federal anti-discrimination laws.
Jeff Bucher of Fond du Lac, Wis., believes a new awareness of his body saved his life.
THOUSANDS of men with prostate cancer could be helped by an "exciting" new drug which potentially represents the biggest step forward in treating the disease for 60 years, researchers revealed yesterday.
London, July 22: Tobacco plant -- a potent carcinogenic agent -- may actually offer the means to treat a certain form of cancer.
Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine .
Men who expect to die from prostate cancer have been offered new hope by a drug which could represent the biggest step forward in treating the disease in 60 years.